BRAF Mutations in Papillary Thyroid Carcinoma: A Genomic Approach Using Probe-Based DNA Capture for Next-Generation

Robert A Smith1,2, Alfred K Lam3,4,5

  • 1Genomics Research Centre, Centre for Genomics and Personalised Health, Queensland University of Technology, Kelvin Grove Campus, Brisbane, QLD, Australia. r157.Smith@qut.edu.au.

Summary

The BRAF V600E mutation is key in papillary thyroid carcinoma. New methods detect other BRAF mutations beyond V600E, improving cancer therapy targets.